Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Journal of Pain and Symptom Management (2015) Vol. 50, Iss. 6, pp. 830-841
Open Access | Times Cited: 153

Showing 76-100 of 153 citing articles:

Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia
Peter D. Cole, Soo Young Kim, Yuelin Li, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 2
Open Access | Times Cited: 5
Psycho-oncology Bibliotherapy Program for Improving the Emotional Wellbeing of People Undergoing Cancer Treatment: Literature Review and Preliminary Findings
Elizabeth Wells, Diane L. Velasquez, Amanda D. Hutchinson, et al.
Journal of the Australian Library and Information Association (2023) Vol. 72, Iss. 3, pp. 270-293
Open Access | Times Cited: 5
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer
Marie Lange, Hélène Castel, Johan Le Fel, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 602-614
Open Access | Times Cited: 15
Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis
Omar Saeed, Lori J. Bernstein, Rouhi Fazelzad, et al.
Journal of Cancer Survivorship (2019) Vol. 13, Iss. 2, pp. 231-243
Closed Access | Times Cited: 14
Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy via modulating their neuroinflammatory and neuroregenerative properties
Ines Klein, Janne Boenert, F. de Lange, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study
Yingchun Zeng, Andy S. K. Cheng, Ting Song, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Computerized cognitive training in post-treatment hematological cancer survivors: a feasibility study
Samantha Mayo, Sean B. Rourke, Eshetu G. Atenafu, et al.
Pilot and Feasibility Studies (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors
Alicia K. Morgans, Joseph Renzulli, Kara Olivier, et al.
Clinical Genitourinary Cancer (2021) Vol. 19, Iss. 5, pp. 467.e1-467.e11
Open Access | Times Cited: 11
Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients
Cecilie R. Buskbjerg, Robert Zachariae, Mads Agerbæk, et al.
Brain Imaging and Behavior (2021) Vol. 16, Iss. 1, pp. 199-210
Closed Access | Times Cited: 11
Cancer and Older Adults: The Introduction
Armin Shahrokni, Helen Pozdniakova, Brandon Nightingale
Geriatric medicine (2024), pp. 783-799
Closed Access | Times Cited: 1
Performance of the Wisconsin Card Sorting Test in Oncopediatric Patients in an Oncology Unit in Cali, Colombia: A Cross-Sectional Observational Study
Ángela María Jiménez, Valeria Santa, Manuel Ceballos Guerrero, et al.
(2024)
Open Access | Times Cited: 1
Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors
Diane Von Ah, Carielle Joy Rio, Allie Carter, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2718-2718
Open Access | Times Cited: 1
Neuropsychological Effects of Chemotherapy
Hee‐Ju Kim, Jung Eun Esther Kim, Sun Ok Jung, et al.
Cancer Nursing (2022) Vol. 46, Iss. 3, pp. E159-E168
Closed Access | Times Cited: 7
Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors
Alexandra M. Gaynor, Anam Ahsan, Duane Jung, et al.
Journal of Cancer Survivorship (2022) Vol. 18, Iss. 2, pp. 466-478
Open Access | Times Cited: 7
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
Javier García‐Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa, et al.
The Breast (2022) Vol. 66, pp. 310-316
Open Access | Times Cited: 7
Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice
Eva Lhuissier, Juliette Aury‐Landas, Valentine Bouët, et al.
Oncotarget (2018) Vol. 9, Iss. 29, pp. 20698-20708
Open Access | Times Cited: 11
Cancer-Related Cognitive Impairment or “Chemobrain:” Emerging Assessments, Treatments, and Targets for Intervention
Dominique Chao, Andrew C. Hale, N. Lynn Henry, et al.
Current Physical Medicine and Rehabilitation Reports (2021) Vol. 9, Iss. 3, pp. 108-118
Closed Access | Times Cited: 9
Chemobrain, Olfactory and Lifestyle Assessment in Onco-Geriatrics: Sex-Mediated Differences between Chemotherapy and Immunotherapy
Sara Invitto, Mariangela Leucci, Giuseppe Accogli, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1390-1390
Open Access | Times Cited: 6
Acceptability and feasibility of cognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review
Melissa A. Carlson, Elizabeth A. Fradgley, Della Yates, et al.
Neuro-Oncology Practice (2022) Vol. 10, Iss. 3, pp. 219-237
Open Access | Times Cited: 6
Assessing objective cognitive impairments in cancer survivors: Features and validity of measures for research and clinical applications
Sun Ok Jung, Jung Eun Esther Kim, Hee‐Ju Kim
Asia-Pacific Journal of Oncology Nursing (2023) Vol. 10, Iss. 11, pp. 100309-100309
Open Access | Times Cited: 3
Co-occuring symptoms in older oncology patients with distinct attentional function profiles
Inger Utne, Borghild Løyland, Ellen Karine Grov, et al.
European Journal of Oncology Nursing (2019) Vol. 41, pp. 196-203
Open Access | Times Cited: 9
Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis?
Brent J. Small, Heather Jim
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 5, pp. 431-432
Open Access | Times Cited: 8
Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy
Inger Utne, Bruce A. Cooper, Christine S. Ritchie, et al.
European Journal of Oncology Nursing (2020) Vol. 48, pp. 101823-101823
Open Access | Times Cited: 8
A Panax quinquefolius-Based Preparation Prevents the Impact of 5-FU on Activity/Exploration Behaviors and Not on Cognitive Functions Mitigating Gut Microbiota and Inflammation in Mice
Renaud Parment, Martine Dubois, Laurence Desrues, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4403-4403
Open Access | Times Cited: 5
Diet quality indices and changes in cognition during chemotherapy
Sylvia L. Crowder, Taylor Welniak, Aasha I. Hoogland, et al.
Supportive Care in Cancer (2022) Vol. 31, Iss. 1
Open Access | Times Cited: 5

Scroll to top